PET/CT Systems Market to Record CAGR of 6.2% Increase in Revenue by 2028

PET/CT Systems Market is expected to account for more than 3.0 billion US$ in terms of value, by the end of 2028 with 6.2% CAGR

A recent market study published by the company "PET/CT Systems Market: Global Industry Analysis 2013 - 2017 and Forecast 2018 - 2028" consists of a comprehensive assessment of the most important market dynamics. Upon conducting thorough research on the historic as well as current growth parameters of the PET/CT systems market, the growth prospects of the market have been obtained with maximum precision. The report features the unique and salient factors that will have a significant impact on the development of the PET/CT systems market during the forecast period. The report will also help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the PET/CT systems market in the upcoming years. The report provides detailed information about the current and future growth prospects of the PET/CT systems market in a comprehensive manner for the better understanding of the readers.

Click on the link for sample report: https://www.persistencemarketresearch.com/samples/27460

Drivers and Restraints:

Drivers:

• Growing incidence of cancer: The increasing prevalence of cancer worldwide is a major driver for the PET/CT systems market. PET/CT imaging plays a crucial role in cancer diagnosis, staging, treatment planning, and monitoring, thereby driving the demand for PET/CT systems.
• Technological advancements: Advancements in PET/CT imaging technology, such as improved image quality, higher spatial resolution, and faster scan times, have increased the adoption of PET/CT systems. These advancements have enhanced the accuracy and efficiency of cancer detection, leading to a higher demand for PET/CT systems.

Restraints:

• High cost of PET/CT systems: PET/CT systems are technologically advanced and expensive medical devices. The high cost of these systems, including the initial purchase cost, maintenance, and operational expenses, can act as a restraint on the market growth, particularly in developing countries with limited healthcare budgets.
• Limited reimbursement coverage: In some regions, the reimbursement coverage for PET/CT imaging procedures may be limited or not available for certain indications. This can discourage the adoption of PET/CT systems, especially in areas where patients heavily rely on insurance coverage for medical expenses.

Competitive Landscape

Examples of some of the key players operating in the PET/CT systems market are Siemens AG; Hitachi, Ltd.; Koninklijke Philips N.V.; Canon, Inc.; General Electric Company; MinFound Medical Systems Co., Ltd; and Neusoft Corporation.

Segmentation

The report on PET/CT systems offers a comprehensive taxonomy of the PET/CT systems market based on the isotopes, applications, product type, end use, modality, and region.

By product type, the PET/CT systems market is segmented into high-range slice PET/CT systems (20), and middle-range slice PET/CT systems (21-64). By modality, the PET/CT systems market is segmented into mobile PET/CT systems and fixed PET/CT systems.

By isotopes, the PET/CT systems market is segmented into 18 F Sodium Fluoride, Gallium, Flurodeoxyglucose, 62 Cu ATSM, Thallium, FMISO, and others. By end use, the PET/CT systems market is segmented into diagnostic centers, hospitals, specialty clinics, and cancer research centers.

By application, the PET/CT systems market is segmented into cardiology, neurology, oncology, and others. The PET/CT systems market has been analyzed across all the regions of Europe, Latin America, North America, East Asia, Oceania, South Asia, and the MEA (Middle East & Africa).

Click on the link for customized report: https://www.persistencemarketresearch.com/request-customization/27460

FAQ

1. What is the revenue potential of the PET/CT systems market across the regions of North America and Europe?
2. Who are the key competitors and what are their portfolios in the PET/CT systems market?
3. What are the major challenges influencing the growth of the PET/CT systems market?
4. How is the intervention of regulatory authorities shaping the growth of the PET/CT systems market?

This report covers a thorough analysis of:

• Market segment
• Market dynamics
• Market size
• Supply demand
• Current Trends/Issues/Challenges
• Competition and related companies
• Technology
• Value chain

Regional analysis includes:

• North America (USA, Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, France, UK, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia and New Zealand)
• Japan
• Middle East and Africa (GCC countries, South Africa, North Africa)

Report highlights:

• Detailed overview of the top markets
• Changing market dynamics of the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• competitive landscape
• Strategies of major players and products provided
• Potential and niche segments, areas showing promising growth
• A neutral view of market performance
• Essential information for market participants to maintain and strengthen their market footprint

Click on the link to access the full report: https://www.persistencemarketresearch.com/checkout/27460

Related reports:

Membrane Technology Market: https://www.persistencemarketresearch.com/market-research/membrane-technology-market.asp
Gamma Knife Market: https://www.persistencemarketresearch.com/market-research/gamma-knife-market.asp

Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About us:
Persistence Market Research's Expertise in Life Sciences and Transformational Health Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic.

This release was published on openPR.